Invivo Therapeutics Holdings's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Invivo Therapeutics Holdings is scheduled to report earnings on April 1, 2019, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -2.70M	$ -1.94M	$ -2.33M	$ -2.46M	$ -2.80M
EBITDA	$ -2.63M	$ -1.83M	$ -2.21M	$ -2.34M	$ -2.69M
Net Income Common Stockholders	$ -2.70M	$ -1.94M	$ -2.33M	$ -2.36M	$ -2.75M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.58M	$ 10.72M	$ 13.15M	$ 16.35M	$ 10.60M
Total Assets	$ 9.58M	$ 13.33M	$ 15.50M	$ 18.82M	$ 13.36M
Total Debt	$ 0.00	$ 754.00K	$ 852.00K	$ 949.00K	$ 1.04M
Net Debt	$ -8.58M	$ -9.97M	$ -12.30M	$ -15.40M	$ -9.55M
Total Liabilities	$ 666.00K	$ 1.76M	$ 2.18M	$ 3.08M	$ 3.26M
Stockholders Equity	$ 8.92M	$ 11.58M	$ 13.48M	$ 15.75M	$ 10.10M
Cash Flow	-
Free Cash Flow	$ -2.24M	$ -2.43M	$ -3.20M	$ -2.21M	$ -2.43M
Operating Cash Flow	$ -2.28M	$ -2.45M	$ -3.20M	$ -2.19M	$ -2.37M
Investing Cash Flow	$ 43.00K	$ 22.00K	$ 2.00K	$ -17.00K	$ -61.00K
Financing Cash Flow	-	-	-	$ 7.96M	$ 0.00

Currency in USD

Invivo Therapeutics Holdings Earnings and Revenue History

Income Statement >

Invivo Therapeutics Holdings Debt to Assets

Balance Sheet >

Invivo Therapeutics Holdings Cash Flow

Cash Flow >

Invivo Therapeutics Holdings Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing